ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling.

导出 OA

翻译打印收藏纠错

第一作者： Chengfei,Liu

第一单位： Department of Urologic Surgery, University of California Davis, Davis, CA, USA.;UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, USA.

作者： Chengfei,Liu ^[1] ; Cameron M,Armstrong ^[2] ; Shu,Ning ^[2] ; Joy C,Yang ^[2] ; Wei,Lou ^[2] ; Alan P,Lombard ^[2] ; Jinge,Zhao ^[2] ; Chun-Yi,Wu ^[3] ; Aiming,Yu ^[3] ; Christopher P,Evans ^[1] ; Clifford G,Tepper ^[3] ; Pui-Kai,Li ^[4] ; Allen C,Gao ^[5]

作者单位： Department of Urologic Surgery, University of California Davis, Davis, CA, USA.;UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, USA. ^[1] Department of Urologic Surgery, University of California Davis, Davis, CA, USA. ^[2] UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, USA.;Department of Biochemistry and Molecular Medicine, University of California Davis, Davis, CA, USA. ^[3] Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH, USA. ^[4] Department of Urologic Surgery, University of California Davis, Davis, CA, USA. acgao@ucdavis.edu.;UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, USA. acgao@ucdavis.edu.;VA Northern California Health Care System, Sacramento, CA, USA. acgao@ucdavis.edu. ^[5]